文献速递瓣膜外科

二尖瓣手术中同期外科消融与手术死亡率的关联

Associations Between Surgical Ablation and Operative Mortality After Mitral Valve Procedures.
PubMed 文献 · Ann Thorac Surg · 2018-01-31

基于胸外科医师学会数据库2011至2014年88,765例二尖瓣修复/置换患者,比较有无房颤及是否行外科消融四组的手术死亡率。有房颤未消融组较无房颤未消融组死亡风险更高(OR 1.15),有房颤行消融组死亡风险降低至与无房颤组无差异(OR 1.08,p=0.13)。

要点

  • 有房颤未行外科消融者手术死亡风险高于无房颤未消融者,OR 1.15。
  • 有房颤行外科消融者死亡风险降低至与无房颤组无显著差异(OR 1.08,p=0.13)。
  • 阵发性与非阵发性房颤的效应相当。

核心结论

  • 二尖瓣手术时有房颤的患者,行外科消融似乎与较低的风险校正手术死亡率相关。

研究设计与样本

  • 研究队列纳入胸外科医师学会数据库2011至2014年间88,765例二尖瓣修复/置换患者,伴或不伴外科消融、冠状动脉旁路移植、室间隔缺损修补及三尖瓣修复。
  • 分为4组:组1无房颤且未消融;组2术前无房颤但接受消融;组3有房颤未消融;组4有房颤接受消融;组3和组4按阵发性与非阵发性房颤分层。
  • 采用逻辑回归,以组1为参照,比较消融、房颤类型及消融技术对死亡率的校正比值比(OR)。

主要发现

  • 组3较组4年龄更高、纽约心脏协会心功能分级更高、再次手术更多、未校正死亡率更高。
  • 相对组1,组3死亡OR为1.15(95%置信区间:1.04至1.27,p<0.01)。
  • 阵发性与非阵发性房颤的OR增量相似。
  • 组4中,同期外科消融与较低的房颤相关相对风险独立相关(OR 1.08),与组1无差异(p=0.13)。
  • 观察到的治疗效果在阵发性与非阵发性房颤及所有基线风险水平上相当。

关键数值与推荐

  • 无房颤未消融组为参照,有房颤未消融组死亡OR 1.15(95%CI 1.04至1.27,p<0.01)。
  • 有房颤行消融组死亡OR 1.08,与无房颤未消融组比较p=0.13。

临床怎么用

  • 原文未据此给出推荐。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Surgical ablation (SA) for atrial fibrillation (AF) concomitant to mitral valve repair/replacement (MVRR) improves longitudinal sinus rhythm. However, the risk of adding SA remains a clinical question. This study examined whether the addition of contemporary SA for AF has an impact on operative outcomes. METHODS: The study cohort included 88,765 MVRR patients with or without SA, coronary artery bypass grafting (CABG), septal defect, and tricuspid repair in The Society of Thoracic Surgeons Database between 2011 and 2014. Group 1 did not have AF (No-AF) and did not receive SA (No-SA); group 2 had No-AF immediately preoperatively but received SA; group 3 had AF but No-SA; and group 4 had AF with SA. Groups 3 and 4 were stratified into paroxysmal versus nonparoxysmal AF. With the use of logistic regression, with group 1 as reference, risk-adjusted odds ratios (OR) for mortality were compared for SA performance, AF type, and SA technique. RESULTS: Group 3 had higher age, New York Heart Association class, redo operations, and unadjusted mortality than group 4. Relative to group 1, group 3 had an OR for mortality of 1.15 (95% confidence interval: 1.04 to 1.27, p < 0.01). OR increments were similar for paroxysmal and nonparoxysmal AF. In group 4, concomitant SA was independently associated with lower AF-related relative risk (OR 1.08), to a level that was not different from group 1 (p = 0.13). Observed treatment effects were equivalent for paroxysmal and nonparoxysmal AF and across all levels of baseline risk. CONCLUSIONS: For patients with AF at the time of mitral operation, the performance of SA seems associated with a lower risk-adjusted operative mortality compared with patients who do not undergo ablation.

来源:Ann Thorac Surg,查看原文。版权归原作者所有。

引用

  1. Rankin JS, Grau-Sepulveda MV, Ad N, et al. Associations Between Surgical Ablation and Operative Mortality After Mitral Valve Procedures. Ann Thorac Surg. 2018. PMID: 29391145. doi:10.1016/j.athoracsur.2017.12.035

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。